Asker Healthcare Group AB
Climate Impact & Sustainability Data (2022)
Reporting Period: 2022
Environmental Metrics
Total Carbon Emissions:682,418 tCO2e/year (Scope 3)
Scope 1 Emissions:2,194 tCO2e/year
Scope 2 Emissions:990 tCO2e/year (market-based)
Scope 3 Emissions:682,418 tCO2e/year
Renewable Energy Share:86%
Total Energy Consumption:23,189 MWh/year
Water Consumption:6,635 m3/year
Waste Generated:1,564 tons/year
Carbon Intensity:Not disclosed
ESG Focus Areas
- Healthy lives
- Climate conscious healthcare
- Fair value chain and safe work environments
Environmental Achievements
- Launched Embra product range, with the Proceed medical examination glove having 27% lower CO2 emissions than comparable products.
- Reduced Scopes 1 and 2 emissions by 3% compared to 2021.
- Replaced stretch film in Norway with recyclable stretch film.
- 85% of electricity used in the Group generated using renewable sources.
Social Achievements
- Launched Asker Business School, providing training in Asker Management Standard, sustainability, and business ethics.
- 98% of employees certified in Asker's Code of Conduct e-learning.
- Employee engagement measured at 73%.
- Donated SEK 500,000 to Save the Children and 84 pallets of medical materials to Ukraine.
Governance Achievements
- Established Asker Management Standard for governance across the Group.
- Implemented a structured M&A process.
- 10% of variable remuneration for selected managers linked to three sustainability targets (all achieved in 2022).
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- More than 50% of own brand sales to be Embra products by 2030.
- All Group companies involved in local joint projects to reduce waste by 2030.
Short-term Goals:
- Reduce greenhouse gas emissions by more than 40% in Scopes 1 and 2 by 2030.
- Reduce emissions from purchased products in relation to gross income by more than 50% by 2030.
Environmental Challenges
- Supply chain disruptions due to geopolitical factors and climate change.
- High environmental impact of healthcare's reliance on single-use products.
- Risks of human rights violations and corruption in some supply chains.
Mitigation Strategies
- Developed contingency plans and processes to address supply chain disruptions.
- Launched Embra product line to reduce the climate footprint of healthcare.
- Implemented Asker Supplier Code of Conduct and Supplier Due Diligence Procedure, conducting 33 audits of third-party manufacturers.
Supply Chain Management
Supplier Audits: 33 audits/year
Responsible Procurement
- Asker Supplier Code of Conduct
- Supplier Due Diligence Procedure
- SA 8000 screening
Climate-Related Risks & Opportunities
Physical Risks
- Drought, flooding, torrential rain impacting supply chain and infrastructure.
Transition Risks
- Changes in business environment linked to climate change affecting suppliers and customers.
Opportunities
- Development of energy-efficient products and services.
Reporting Standards
Frameworks Used: GRI Standards
Certifications: ISO 9001, ISO 13485, ISO 14001, ISO 45001
Third-party Assurance: Ernst & Young AB
UN Sustainable Development Goals
- Goal 3: Good health and well-being
- Goal 5: Gender equality
- Goal 8: Decent work and economic growth
- Goal 12: Responsible consumption and production
- Goal 13: Climate action
- Goal 16: Peace, justice and strong institutions
Asker's operations and sustainability strategy contribute to these goals through improved health outcomes, fair labor practices, sustainable product development, emission reductions, and ethical business conduct.
Sustainable Products & Innovation
- Embra product line (medical supplies with lower climate impact).
Awards & Recognition
- EcoVadis Gold Medal for sustainability